http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62149628-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b04bd4d7c6f36967c92951f4e6ebb534
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 1985-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46d81ee070abbb7750983629db6e216d
publicationDate 1987-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S62149628-A
titleOfInvention Antibiotic-containing pharmaceutical composition
abstract PURPOSE: The titled pharmaceutical composition, obtained by blending an antibiotic with cyclodextrin and collagen and having enhanced stability and absorbability of the antibiotic. n CONSTITUTION: A pharmaceutical composition containing at least one selected from cyclodextrin and collagen and an antibiotic, e.g. cephaloridine or ce phazoline. The cyclodextrin is a nonreducing maltooligosaccharide in which D-glucose is linked in a ring form and a cavity is provided in the center of a cyclic structure. In some cases, the cyclodextrin forms a clathrate compound with a drug and stabilizes. The collagen is albuminoid accounting for a principal ingredient in the skin, bone, etc., of calves, etc., and an extract from the above- mentioned raw material is normally used as the collagen to be used in the composition. A phosphilipid is further preferably blended in composition and the cyclodextrin, collagen and phospholipid promote the absorption of the antibi otic. The local convergence of the antibiotic is further enhanced. n COPYRIGHT: (C)1987,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6046177-A
priorityDate 1985-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426334837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396023
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589780
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46874763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500773

Total number of triples: 30.